Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Working Capital/Sales(x) 5.104.845.319.4012.11

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 5.10 based on Mar2023 Consolidated results.
Year Working Capital/Sales
Mar20235.10
Mar20224.84
Mar20215.31
Mar20209.40
Mar201912.11

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2023 5.1
5.37
Mar2022 4.84
-8.85
Mar2021 5.31
-43.51
Mar2020 9.4
-22.38
Mar2019 12.11 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹68,140.2 Cr 1% 5.7% 86.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,026.0 Cr 0.5% -5.7% 55.1% Stock Analytics
CIPLA ₹114,925.0 Cr 1.1% -4.4% 55.5% Stock Analytics
DIVIS LABORATORIES ₹105,128.0 Cr -0.7% 9.4% 21.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,109.0 Cr 0.1% 1.1% 28.1% Stock Analytics
ZYDUS LIFESCIENCES ₹102,736.0 Cr 6% 2.8% 93.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1%

5.7%

86.4%

SENSEX

0.2%

-0.2%

20.9%


You may also like the below Video Courses